Demand is soaring for extracorporeal membrane oxygenation (ECMO), a heart-lung bypass machine. Usually a last-resort treatment, ECMO can help the non-elderly survive COVID-19. However, as Blake Farmer ...
Please provide your email address to receive an email when new articles are posted on . Patients who underwent ECMO for COVID-19 pneumonia or non-COVID-19 pneumonia were balanced based on ...
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results